Sunitinib 50 mg Capsule: The Global Standard for Multi-Targeted Tyrosine Kinase Inhibition
Are you looking for a premier Sunitinib 50 mg capsule exporter from India? Ernest Impex, a specialized division of the Group of Ernest Pharmaceutical Pvt. Ltd., stands as a high-authority global supplier and bulk distributor of advanced oncology therapies. We manage a robust, cold-chain-compliant supply network serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical cancer treatments are delivered with 100% pharmaceutical integrity.
Comprehensive Product Profile: What is Sunitinib 50 mg?
Sunitinib 50 mg capsule is an oral, multi-targeted receptor tyrosine kinase inhibitor (TKI) that has revolutionized the treatment of several solid tumors. It is the active pharmaceutical ingredient (API) found in world-renowned brands such as Sutent, as well as high-quality Indian generics like Sutib, Sutinat, and Nitnib.
The 50 mg strength is the standard therapeutic dose designed to disrupt the cellular signaling pathways that malignant tumors rely on for growth, survival, and blood vessel formation.
Primary Therapeutic Indications
Sunitinib 50 mg is clinically indicated for the following:
Metastatic Renal Cell Carcinoma (mRCC): A frontline treatment for advanced kidney cancer.
Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed or who are intolerant to Imatinib.
Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in patients with unresectable or metastatic disease.
Mechanism of Action: How Sunitinib Works
Sunitinib employs a multi-pathway attack strategy, making it more effective than single-target therapies:
VEGF Receptor Blockade: It inhibits all receptors for vascular endothelial growth factors (VEGFR-1, -2, -3). This prevents angiogenesis, the process where tumors create their own blood supply.
PDGF Receptor Inhibition: By targeting Platelet-Derived Growth Factor Receptors (PDGFR-Ξ± and -Ξ²), it disrupts the communication between cancer cells and their supporting environment.
KIT & FLT3 Targeting: It binds to the stem cell factor receptor (KIT) and Fms-like tyrosine kinase-3 (FLT3), interrupting the internal signals that drive rapid, uncontrolled cell division.
Dual Impact: By simultaneously starving the tumor of nutrients and halting its growth signals, Sunitinib significantly slows disease progression.
Administration, Storage, and Safety
Standard Dosage: Usually taken once daily for a 4-week-on/2-week-off cycle, or as directed by an oncologist.
Storage Requirements: Store at controlled room temperature (20Β°C to 25Β°C). Keep the capsules in their original container to protect them from moisture and light.
Clinical Monitoring:
Hypertension: Blood pressure must be monitored regularly.
Thyroid Function: Routine checks for hypothyroidism are necessary.
Cardiac Health: Periodic assessment of left ventricular ejection fraction (LVEF) is recommended.
Hepatotoxicity: Liver function tests (LFTs) should be conducted periodically.
Why Choose Ernest Impex for Sunitinib 50 mg?
Verified Indian Oncology Exporter: We provide direct access to top-tier Indian pharmaceutical manufacturers, ensuring competitive bulk pricing and authentic products.
Specialized Global Logistics: Our team handles complex international documentation and cold-chain requirements for Washington, London, Bangkok, Canberra, Singapore, and Kingston.
Quality Assurance: All shipments are accompanied by essential B2B documentation, including GMP compliance certificates and batch-specific Certificates of Analysis (COA).
Supply Chain Resilience: We prioritize 2026 standards of digital traceability and consistent stock availability for hospital networks and distributors.
π Contact Ernest Impex β Pharmaceutical Exporter from India
[GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.]
π Websites:
π§ Email:
π¦ Business Type: Exporter | Bulk Supplier | Distributor
π² WhatsApp: +91 93599 02383
π
